| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 12,344 | $49.20 | $607,324.80 | View Details Filing |
| Apr 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 2,656 | $49.92 | $132,587.52 | View Details Filing |
| Mar 2, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 5,900 | $41.73 | $246,207.00 | View Details Filing |
| Mar 2, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 9,100 | $42.49 | $386,659.00 | View Details Filing |
| Feb 2, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 14,043 | $32.87 | $461,593.41 | View Details Filing |
| Feb 2, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 957 | $31.82 | $30,451.74 | View Details Filing |